Results 31 to 40 of about 994,628 (384)
Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis
Nature Reviews Cardiology, 2021 Nanotechnology could improve our understanding of the pathophysiology of atherosclerosis and contribute to the development of novel diagnostic and therapeutic strategies to further reduce the risk of cardiovascular disease.
Wei Chen +5 more
semanticscholar +1 more source
When Is Atherosclerosis Not Atherosclerosis? [PDF]
Arteriosclerosis, Thrombosis, and Vascular Biology, 2000 To the Editor: When is atherosclerosis not atherosclerosis? In the last decade, there have been 2 revolutions in the study of atherosclerosis. On the one hand, a more sophisticated appreciation of the relationship between the morphology and fate of human atherosclerotic plaques and clinical outcomes has been developed.
openaire +2 more sources
Data in Brief, 2016 The data presented in this article describe an effect of N-acetylneuraminic acid and/or quercetin on the inflammatory proteins expressions (TNF-α, ICAM-1, VCAM-1 and MOMA-2) and the N-acetylneuraminic acid (NANA) levels of apolipoprotein E-deficient mice
Rongrong Dong +13 more
doaj +1 more source
Circulation Research, 2016 Advances in atherosclerosis imaging technology and research have provided a range of diagnostic tools to characterize high-risk plaque in vivo; however, these important vascular imaging methods additionally promise great scientific and translational applications beyond this quest.
Tarkin, Jason M +7 more
openaire +4 more sources
Alcohol and atherosclerosis [PDF]
Anais da Academia Brasileira de Ciências, 2001 Atherosclerosis is manifested as coronary artery disease (CAD), ischemic stroke and peripheral vascular disease. Moderate alcohol consumption has been associated with reduction of CAD complications. Apparently, red wine offers more benefits than any other kind of drinks, probably due to flavonoids. Alcohol alters lipoproteins and the coagulation system.
DA LUZ, PROTASIO L., COIMBRA, SILMARA R.
openaire +6 more sources
Journal of Lipid Research, 1993 Probucol treatment results in an increase in plasma concentrations of cholesteryl ester transfer protein (CETP) which may account, in part, for the effects of this agent on plasma concentrations of HDL cholesterol. We have examined the mechanism by which
EM Quinet +5 more
doaj +1 more source
Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect? [PDF]
, 2017 Data from basic science experiments is overwhelmingly supportive of the causal role of immune-inflammatory response(s) at the core of atherosclerosis, and therefore the theoretical potential to manipulate the inflammatory response to prevent ...
Abbas +173 more
core +1 more source
Nature, 2000 Atherosclerosis, a disease of the large arteries, is the primary cause of heart disease and stroke. In westernized societies, it is the underlying cause of about 50% of all deaths. Epidemiological studies have revealed several important environmental and genetic risk factors associated with atherosclerosis.
openaire +2 more sources
Phosphatidylserine in atherosclerosis [PDF]
Current Opinion in Lipidology, 2016 Purpose of review It is now widely acknowledged that phosphatidylserine is a multifunctional bioactive lipid. In this review, we focus on the function of phosphatidylserine in modulating cholesterol metabolism, influencing inflammatory response and regulating coagulation system, and discuss promising phosphatidylserine-based ...
Darabi, Maryam, Kontush, Anatol
openaire +4 more sources
Journal of Lipid Research, 2012 Stable isotope tracer studies of apoprotein flux in rodent models present difficulties as they require working with small volumes of plasma. We demonstrate the ability to measure apoprotein flux by administering either 2H- or 18O-labeled water to mice ...
Haihong Zhou +14 more
doaj +1 more source